MiR-22 inhibits myocardial fibrosis in rats with myocardial infarction by targeting PTEN/Akt/mTOR signaling pathway
Cellular and Molecular Biology · 2024
DOI: 10.14715/cmb/2024.70.1.4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular and Molecular Biology, 2024. Verfasst von Bolin Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency, Kaiping Central Hospital, Jiangmen, China. libolin198309@163.com. Hauptthemen laut MEDLINE: MicroRNAs, Myocardial Infarction, Cardiomyopathies. Die Arbeit wurde bisher 9-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
This study aimed to evaluate the effects of miR-22 on myocardial fibrosis in rats with myocardial infarction (MI) and to further explore the possible underlying mechanism. A total of 80 rats were randomly divided into Sham group, miR-22 overexpression group, MI group or MI + miR-22 overexpression group. Reverse transcription-polymerase chain reaction (RT-PCR) results showed that compared with Sham group, miR-22 expression level in myocardial tissues of rats decreased significantly in MI group. Overexpression of miR-22 could remarkably relieve cardiac insufficiency in MI rats, increase EF% and FS%, and reduce collagen deposition and the mRNA expression level of fibrosis-promoting genes in myocardial tissues of MI rats. The cross-sectional area of myocardial cells in MI + miR-22 mimic group was smaller than that in MI group. According to the results of immunohistochemical staining, overexpression of miR-22 notably reduced the level of oxidative stress marker 4-HNE in myocardial tissues of MI rats. Meanwhile, myocardial cells in MI + miR-22 mimic group exhibited a prominently lower apoptosis rate than those in MI group. Furthermore, Western blotting results demonstrated that overexpression of miR-22 inhibited the activation of the phosphatase and tensin homolog deleted on chromosome ten (PTEN)/Akt/mTOR signaling pathway in myocardial tissues of MI rats. The inhibitory effects of miR-22 on myocardial fibrosis and hypertrophy after MI in rats may be related to its inhibition on the PTEN/Akt/mTOR signaling pathway. All our findings suggested that miR-22 is expected to become a targeted drug for the clinical treatment of MI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Emergency, Kaiping Central Hospital, Jiangmen, China. libolin198309@163.com.
- Department of Emergency, Kaiping Central Hospital, Jiangmen, China. 87142858@qq.com.
- Department of Emergency, Kaiping Central Hospital, Jiangmen, China. yuanjunlv@163.com.
- Department of Cardiovascular, Kaiping Central Hospital, Jiangmen, China. tanyongjin840801@163.com.
- Intensive Care Unit, the Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China. sam11124@126.com.
Zitieren
APA
Li, B., Liang, C., Lv, Y., Tan, Y., & Chen, W. (2024). MiR-22 inhibits myocardial fibrosis in rats with myocardial infarction by targeting PTEN/Akt/mTOR signaling pathway. Cellular and Molecular Biology. https://doi.org/10.14715/cmb/2024.70.1.4
Vancouver
Li B, Liang C, Lv Y, Tan Y, Chen W. MiR-22 inhibits myocardial fibrosis in rats with myocardial infarction by targeting PTEN/Akt/mTOR signaling pathway. Cellular and Molecular Biology. 2024. doi:10.14715/cmb/2024.70.1.4
BibTeX
@article{Li2024,
author = {Li, Bolin and Liang, Chunna and Lv, Yuanjun and Tan, Yongjin and Chen, Weiyan},
title = {MiR-22 inhibits myocardial fibrosis in rats with myocardial infarction by targeting PTEN/Akt/mTOR signaling pathway},
journal = {Cellular and Molecular Biology},
year = {2024},
doi = {10.14715/cmb/2024.70.1.4}
}
EUVIMED